|
You can mail in your membership or use PayPal and join on line.
|
|
You can mail in your membership or use PayPal and join on line.
|
Policy Statement Number 13 July 2003 The development of Oral Swabs for toxicology testing shows potential in providing an alternative means to test for drug use and to assess if a patient is taking their medication as prescribed. Such advances in technology should improve the quality of treatment that programs can provide to patients. However…
Unifying the Treatment Community This special pre-conference meeting is divided into two sessions – a morning and afternoon session. These sessions have been developed by the Advocacy Coalition: National Alliance of Methadone Advocates (NAMA), Advocates for Recovery through Medicine (ARM), Advocates For the Integration of Recovery and Methadone (AFIRM), Virginia Alliance of Methadone Advocates (VAMA),…
FALSE! Current research shows that doses below 60 mg/day are “not effective and hence not appropriate” and that low dose policies for pregnant and non-pregnant patients are associated with increased drug use as well as reduced program retention. Medical withdrawal of opioid dependent women is not recommended in pregnancy because of increased risk to the…
Charleston Daily Mail Tuesday February 17, 2004. Boone County man speaks out, officials defend At first, it all seemed so perfectly legal and innocent. A naive Travis Barker swallowed what he thought was a harmless prescription pill, just 20 mg of a popular painkiller called OxyContin. He was told that day about four years ago…
Policy Statement Number 9 August 2002 There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration…
